Key gene found to prevent muscle breakdown in muscular dystrophy

Jazz Phar­ma­ceu­ti­cals said Thurs­day that the high­est dose of su­ve­cal­tamide failed a Phase 2b tri­al in es­sen­tial tremor, a neu­ro­log­i­cal con­di­tion that caus­es in­vol­un­tary shak­ing

Experts discussed the EU harmonisation of HTAs at the Bio Europe 2023 conference. Credit: ‘ a screenshot of the panel that was also streamed virtually.